Form 4: Cigna Group Director Elder Granger Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Director Elder Granger exercised stock options and sold shares of Cigna Group common stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On March 14, 2025, Elder Granger, a director of Cigna Group, exercised stock options to acquire 2,376 shares of Cigna common stock at a price of $151.4786 per share.
- On the same day, Granger sold 2,376 shares of Cigna common stock at a price of $310.35 per share.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on December 11, 2024.
- Following these transactions, Granger directly owns 5,471 shares of Cigna common stock.
- Granger also holds options to purchase 0 shares of Cigna common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of insider trading activity under a pre-arranged plan. There's no indication of positive or negative implications for the company.
Positives
- The director's transactions are being conducted under a pre-arranged 10b5-1 trading plan, which can provide transparency and reduce concerns about insider trading.
Future Outlook
There is no specific future outlook provided in this document.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The use of a 10b5-1 plan is a common practice to allow insiders to sell shares without raising concerns about insider trading.
Comparison to Industry Standards
- Monitoring insider transactions is a standard practice in corporate governance.
- Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also have their executives and directors file similar Form 4 reports when they trade company stock.
- The use of 10b5-1 plans is widespread among publicly traded companies to manage insider trading risks.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| December 11, 2024 | Date the reporting person adopted a Rule 10b5-1 trading plan |
| December 27, 2024 | Date of Power of Attorney |
| March 14, 2025 | Date of stock option exercise and share sale |
| March 17, 2025 | Date of Form 4 filing |
| May 4, 2026 | Expiration date of the Employee Stock Options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.